期刊文献+

和血明目片治疗视网膜静脉阻塞的临床观察 被引量:8

Clinical observation of hexuemingmu tablets in the treatment of retinal vein occlusion
下载PDF
导出
摘要 目的:探究和血明目片治疗视网膜静脉阻塞的疗效。方法:将92例93眼患者随机分为两组,治疗组50例51眼给予和血明目片治疗,对照组42例42眼给予血塞通片治疗。根据视力恢复情况、荧光血管造影、自觉症状有无改善进行观察。结果:治疗组治愈17眼,有效27眼,无效7眼,总有效率86%。对照组治愈8眼,有效17眼,无效17眼,总有效率60%。结论:和血明目片能促进视网膜出血渗出吸收,恢复视网膜功能,提高视网膜静脉阻塞患者的视功能。经比较,和血明目片在提高视力,改善眼底方面的疗效优于血塞通片(P<0.05)。 AIM:To explore hexuemingmu tablets in the treatment of retinal vein occlusion.METHODS:Totally 92 patients were randomly divided into two groups,51 eyes of 50 patients in treatment group were given hexuemingmu tablets treatment,42 eyes of 42 patients in the control group were given xuesaitong tablets treatment.According to the recovery of visual acuity,fluorescein angiography,with or without improvement of symptoms,they were observed.RESULTS:A total of 17 eyes were cured in the treatment group,and it was effective in 27 eyes,invalid in 7 eyes,the total effective rate was 86%.8 eyes in the control group were cured,and it was effective in 17 eyes,ineffective in 17 eyes,the total effective rate was 60%.CONCLUSION:Hexuemingmu tablets can promote absorption of retinal hemorrhage,retinal function recovery,and improve visual function in patients with retinal vein occlusion.By comparison,hexuemingmu tablets can better improve vision and fundus than xuesaitong tablets(P〈0.05).
作者 张绪富 杨霞
出处 《国际眼科杂志》 CAS 2011年第4期724-725,共2页 International Eye Science
关键词 和血明目片 视网膜静脉阻塞 hexuemingmu tablets retinal vein occlusion
  • 相关文献

参考文献5

二级参考文献81

  • 1高伟,王雨生.同型半胱氨酸与视网膜静脉阻塞[J].国际眼科杂志,2005,5(1):142-144. 被引量:5
  • 2马志中,李宝民,窦洪亮,韩素义,任高英,李晓陵,魏世辉,侯宝杰,段国升,张纪,周宝标.经眼动脉超选插管溶栓治疗视网膜中央动脉阻塞[J].中华眼科杂志,1996,32(6):445-447. 被引量:30
  • 3Weger M, Stanger O, Deutschmann H. Hyperhomocyst (e) inemia, but not methylenetetrahy drofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion. Ophthalmology, 2002, 109 (6): 1105-1109.
  • 4Boyd S.Owens D,Gin T,el al.Plamaa homocysteine,methylenetetrahy- drofolate reducates C677T and factor Ⅱ G20210A polymorphisms, factor Ⅷ, and VWF in central retinal vein occlusion. Br J Ophthalmol, 2001, 85(11) : 1313 - 1315.
  • 5Marcucci R, Giusti B. Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion. ThrombRes, 2003, 110 (1): 7-12.
  • 6Weger M, Stanger O, Deutschmann H.Hyperhomocyst (e)inemia and MTHFR C677T gentypes in patients with central retinal vein occlusion. Graefes Arch Clin Ophthalmol, 2002, 240(4) :286 - 290.
  • 7Ames PR, Pyke S, Ionnaccone L, et al. Antiphospholipid antibodies, haemostatie variables and thrombosis - a survey of 144 patients. Thromb Haemost, 1995, 73(5):768-773.
  • 8Gleuck J, Bell H, Vadlamani L. Heritable thrombophilia and hypofibri - nolysis Possible causes of retinal vein occlusion. Arch Ophthalmol, 1999, 117(7):43-49.
  • 9Lahey JM, Tunc M, Keamey JJ. Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are le~ than 56 years old. Ophthalmology, 2002, 109 (6) :126 - 131.
  • 10Hvarfner C, Hillarp A, Larsson J.Influence of factor V Leiden on the development of neovascularisation ,secondary to central retinal vein occlusion. Br J Ophthalmol, 2003, 87(3):305 - 306.

共引文献92

同被引文献55

引证文献8

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部